Medical Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
The partnership further extends the accessibility of EDAPs High Intensity Focused Ultrasound (HIFU) technology to one of the principal markets in Europe.
Marc Oczachowski, CEO
FREMONT, CA: EDAP TMS SA, the global leader in robotic energy-based therapies, announced that the company has signed an exclusive distribution agreement with AB Medica, a leading distributor of medical technologies across Italy.
EDAP TMS develops, manufactures, promotes, and distributes minimally invasive medical devices for various pathologies using ultrasound technology globally. By merging the latest technologies in imaging and treatment modalities in its comprehensive range of Robotic HIFU devices, EDAP TMS introduced the Focal One in Europe and the U.S. to answer all needs for ideal prostate tissue ablation.
Marc Oczachowski, Chairman and Chief Executive Officer, EDAP, commented, “We are very pleased to partner with AB Medica, a widely recognized leader in Italy for the distribution of cutting-edge medical technologies. This is clearly a step forward for EDAP in its HIFU adoption and commercialization program in Europe, as Italy is the fourth largest market for medical devices. Notably, AB Medica had already been distributing ExactVu, so they are familiar with our product line and have been able to incorporate Focal One very quickly. AB Medica also has extensive experience in the distribution of robotic prostate surgery solutions, so they are the perfect fit for us. We look forward to a very successful partnership.”
Founded in 1984, AB Medica is a premier in the production and distribution of medical technologies and a reference point for robotic surgery and technological innovation in healthcare. “We are thrilled to have entered into this distribution agreement with EDAP, which is already a highly recognized name in Italy. This partnership will not only see us strengthen our presence in high definition ultrasound with ExactVu, but will also give us the opportunity to become a reference point in lithotripsy and HIFU, rounding out what will be an outstanding urology product portfolio. We are confident that we will meet EDAPs expectations, and we are eager to start this new adventure with great enthusiasm,” said Filippo Pacinotti, Business Director, AB Medica.
Read Also
